210 related articles for article (PubMed ID: 19176006)
21. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
[TBL] [Abstract][Full Text] [Related]
22. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
Jalaeikhoo H; Khajeh-Mehrizi A
PLoS One; 2015; 10(5):e0126925. PubMed ID: 25970182
[TBL] [Abstract][Full Text] [Related]
23. [Splenectomy in programmed therapy of aplastic anemia].
Mikhaĭlova EA; Savchenko VG; Ustinova EN; Vinogradova MA; Kokhno AV; Karagiulian SR; Danishian KI; Grzhimolovskiĭ AV; Zakharov GN
Ter Arkh; 2006; 78(8):52-7. PubMed ID: 17078218
[TBL] [Abstract][Full Text] [Related]
24. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
[TBL] [Abstract][Full Text] [Related]
25. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children.
Alsultan A; Goldenberg NA; Kaiser N; Graham DK; Hays T
Pediatr Blood Cancer; 2009 May; 52(5):626-30. PubMed ID: 19148946
[TBL] [Abstract][Full Text] [Related]
26. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
Song MK; Chung JS; Joo YD; Kim YS; Kim SH; Seol YM; Shin HJ; Choi YJ; Cho GJ
Eur J Haematol; 2009 Jul; 83(1):72-8. PubMed ID: 19220415
[TBL] [Abstract][Full Text] [Related]
27. [Aplastic anemia with macrocytic anemia: a study based on long-term follow-up].
Li YM; Li XX; Sun H; Sun L; Wan DM; Liu LX; Chen SM; Chen SQ; Liu SJ; Zheng YZ; Zou DB
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):117-21. PubMed ID: 23611217
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and treatment of children with aplastic anemia.
Kurre P; Johnson FL; Deeg HJ
Pediatr Blood Cancer; 2005 Nov; 45(6):770-80. PubMed ID: 15706582
[TBL] [Abstract][Full Text] [Related]
29. [Effectiveness of immunosuppressive therapy for childhood aplastic anemia and its predictive factors].
Zhao FY; Xu XJ; Song H; Yang SL; Tang YM
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):567-70. PubMed ID: 22898273
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology and clinical long-term outcome of childhood aplastic anemia in Korea for 15 years: retrospective study of the Korean Society of Pediatric Hematology Oncology (KSPHO).
Jeong DC; Chung NG; Kang HJ; Koo HH; Kook H; Kim SK; Kim SY; Kim HS; Kim HM; Park KD; Park SK; Park JS; Park JE; Park HJ; Park YS; Seo JJ; Sung KW; Shin HY; Ahn HS; Ryu KH; Ryu KH; Yoo ES; Lyu CJ; Lee KS; Lee KC; Lee SY; Lee YH; Lim YT; Lim YJ; Jung HL; Cho B; Choi YM; Hah JO; Hwang TJ; Kim HK
J Pediatr Hematol Oncol; 2011 Apr; 33(3):172-8. PubMed ID: 21325968
[TBL] [Abstract][Full Text] [Related]
31. [Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia].
Mrsić M; Seiwerth RS; Labar B; Bogdanić V; Nemet D; Duraković N; Mikulić M; Sertić D; Aurer I; Radman I; Zupancić-Salek S
Acta Med Croatica; 2009 Jun; 63(3):209-14. PubMed ID: 19827347
[TBL] [Abstract][Full Text] [Related]
32. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
[TBL] [Abstract][Full Text] [Related]
33. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
Pongtanakul B; Das PK; Charpentier K; Dror Y
Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
[TBL] [Abstract][Full Text] [Related]
34. [Studies on the predictors of response to immunosuppressive therapy in severe aplastic anemia patients].
Mu XY; Chang H; Liu T; Gong YP; Niu T; Qin H; Ma HB; Meng WT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):897-900. PubMed ID: 19950609
[TBL] [Abstract][Full Text] [Related]
35. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
Bacigalupo A; Valle M; Podestà M; Pitto A; Zocchi E; De Flora A; Pozzi S; Luchetti S; Frassoni F; Van Lint MT; Piaggio G
Exp Hematol; 2005 Jul; 33(7):819-27. PubMed ID: 15963858
[TBL] [Abstract][Full Text] [Related]
36. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of aplastic anemia--aims and development of the SAA 94 pilot protocol].
Führer M; Bender-Götze C; Ebell W; Friedrich W; Kohne E
Klin Padiatr; 1994; 206(4):289-95. PubMed ID: 7967425
[TBL] [Abstract][Full Text] [Related]
38. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia.
Liu C; Li Z; Sheng W; Fu R; Li L; Zhang T; Wu Y; Xing L; Song J; Wang H; Shao Z
Immunol Invest; 2014; 43(5):491-503. PubMed ID: 24661133
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia.
Timeus F; Crescenzio N; Doria A; Foglia L; Linari A; Giaccone M; Pastore G; di Montezemolo LC; Ramenghi U; Saracco P
Exp Hematol; 2005 May; 33(5):597-604. PubMed ID: 15850838
[TBL] [Abstract][Full Text] [Related]
40. [Apoptosis of bone marrow cells aplastic anemia patients treated with cyclosporin A].
Ren C; Zhang M; Xu C; Zhang T; Peng J; Li W; Wang W
Zhonghua Xue Ye Xue Za Zhi; 2001 Apr; 22(4):189-92. PubMed ID: 11877071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
